AI-derived 3D body composition predicts prognosis of chemoimmunotherapy in small cell lung cancer: a multicenter study
Authors:
Open Access
- 12 October 2026
- journal article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 14 (10) , e014952
Abstract
Background Small cell lung cancer (SCLC) has a poor prognosis despite standard first-line chemoimmunotherapy. Reliable, non-invasive biomarkers for risk stratification are urgently needed. Three-dimensional (3D) body composition (BC) analysis from chest CT scans offers a promising approach to assess systemic metabolic status.Methods In this multicenter study, we analyzed patients treated with first-line chemoimmunotherapy across five institutions. Using a deep learning model, 3D BC parameters were automatically extracted from baseline chest CTs. We evaluated their associations with overall survival (OS) and progression-free survival using Kaplan-Meier and Cox regression analyses. A total of 101 machine learning model configurations were evaluated to develop predictive models, and the SHapley Additive exPlanations method was applied to enhance model interpretability. Additionally, we investigated the association between BC parameters and CD8 + T-cell infiltration in the tumor microenvironment.Results Among 575 patients (training: 161; internal validation: 69; external validation: 345), all four 3D BC indices significantly stratified OS. Multivariable Cox analysis showed that higher skeletal muscle volume index was independently associated with better OS (HR=0.956, 95% CI 0.928 to 0.985, p=0.003), whereas higher visceral fat volume index was associated with worse OS (HR=1.017, 95% CI 1.002 to 1.032, p=0.026). 3D BC provided more pronounced prognostic stratification than conventional two-dimensional measures and body mass index. The selected linear discriminant analysis model achieved area under the curves of 0.756, 0.781, and 0.783 in the training, internal validation, and external validation cohorts, respectively. In an exploratory subset of 35 patients, higher skeletal muscle volume index was associated with increased intratumoral CD8+T cell density.Conclusions Higher skeletal muscle volume index was associated with better OS, whereas higher visceral fat volume index was associated with worse OS. Automated 3D BC may provide complementary non-invasive prognostic information in patients with SCLC receiving first-line chemoimmunotherapy.Keywords
Funding Information
- Interdisciplinary Research Program of HUST (2025JCYJ071)
- Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0522800)
- Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0522806)
- National Natural Science Foundation of China (82172034)
- National Natural Science Foundation of China (82472058)
- National Natural Science Foundation of China (82502329)
- National Natural Science Foundation of China (825B2054)
- Research Fund of Tongji Hospital, Tongji Medical College, HUST (AI2025B06)
This publication has 38 references indexed in Scilit:
- Automated CT-derived body composition predicts pathologic response to neoadjuvant immunotherapy in non–small cell lung cancerCancer Letters, 2026
- AI-based CT assessment of sarcopenia in borderline resectable pancreatic Cancer: A narrative review of clinical and technical perspectivesComputers in Biology and Medicine, 2025
- Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunityCancer Immunology, Immunotherapy, 2024
- Three‐dimensional body composition parameters using automatic volumetric segmentation allow accurate prediction of colorectal cancer outcomesJournal of Cachexia, Sarcopenia and Muscle, 2023
- Chest computed tomography‐derived muscle mass and quality indicators, in‐hospital outcomes, and costs in older inpatientsJournal of Cachexia, Sarcopenia and Muscle, 2022
- Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancerCancer Medicine, 2020
- Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor ImmunityCell, 2020
- Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized PotentialAdvances in Therapy, 2019
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung CancerCancer Cell, 2019
- Ridge Regression in Prediction Problems: Automatic Choice of the Ridge ParameterGenetic Epidemiology, 2013